Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Caregiving as a Risk Factor for Mortality
1999 Standout
Unplanned Extubations in the Adult Intensive Care Unit
1998
Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension
2011 StandoutNobel
Patterns of medical practice in cystic fibrosis: Part II. Use of therapies
1999
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
2007
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease
1999
Idiopathic pulmonary fibrosis
2017 Standout
Cystic Fibrosis Pulmonary Guidelines
2009
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
THERAPIES AIMED AT AIRWAY INFLAMMATION IN CYSTIC FIBROSIS
1998
IL-23 mediates inflammatory responses to mucoidPseudomonas aeruginosalung infection in mice
2006
Cystic fibrosis
2016 Standout
Cystic fibrosis
2003
Diagnosis and Treatment of Cystic Fibrosis
2000
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Pancreatic enzyme replacement therapy for people with cystic fibrosis
2014
Heterozygous HIF‐1α deficiency impairs carotid body‐mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia
2006 StandoutNobel
Managing Cystic Fibrosis
2011
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Cystic Fibrosis Pulmonary Guidelines
2007
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Defining an exacerbation of pulmonary disease in cystic fibrosis*
2001
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Lung disease in cystic fibrosis—an updated concept
1990
Anti-inflammatory therapy in cystic fibrosis
2005
Pulmonary Outcomes in Survivors of Childhood Cancer
2011
Standardisation of spirometry
2005 Standout
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
2003
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Drug administration by jet nebulization
1998
Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis
2001
Asthma
2017 Standout
Reproducibility of forced expiratory flow and volume measurements in infants with bronchiolitis
1999
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
A Comparison of the Availability of Tobramycin for Inhalation From Vented vs Unvented Nebulizers
1998
Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation
2000 Standout
Management of Pulmonary Disease in Patients with Cystic Fibrosis
1996
General considerations for lung function testing
2005 Standout
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Dornase alfa in early cystic fibrosis lung disease
2002
Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis
2002
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
1995
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
1999
Interpretative strategies for lung function tests
2005 Standout
Asthma
2001 Standout
Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: A pilot study†‡
2001
The Effect of High Doses of Inhaled Salbutamol and Ipratropium Bromide in Patients With Stable Cystic Fibrosis
1993
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
2015
The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis
1995
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis
1997
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
1994
Cystic Fibrosis Pulmonary Guidelines
2013
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities
2001
HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase
2015 StandoutNobel
Airway Mucus Function and Dysfunction
2010 Standout
Detecting early structural lung damage in cystic fibrosis
2002
Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis
2002
Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial
2010
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
1999 Standout
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
2005 Standout
Predictive 5-Year Survivorship Model of Cystic Fibrosis
2001
Recent Advances in Pulmonary Medicine
1993
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
2015
The Role of Inflammation in the Pathophysiology of CF Lung Disease
2002
Association between lipid peroxidation and inflammation in obstructive sleep apnoea
2006
Long-term Repeatability of Induced Sputum Cells and Inflammatory Markers in Stable, Moderately Severe COPDa
2003
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
2007 Standout
Development and Validation of the Cystic Fibrosis Questionnaire in the United States
2005
Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis
2001
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Cystic fibrosis
2009
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation
2009
Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
2013
Outcome measures for clinical trials in cystic fibrosis Summary of a Cystic Fibrosis Foundation Consensus Conference
1994
Lung function testing in infants with cystic fibrosis: Lessons from the past and future directions
2001
The Use of Anti-inflammatory Medications in Cystic Fibrosis
1999
Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis
1996
Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction
2001
Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic Bronchopulmonary Pseudomonas aeruginosa Infection
1997
Do Inhaled Corticosteroids Inhibit Growth in Children?
2001
Early Respiratory Infection Is Associated with Reduced Spirometry in Children with Cystic Fibrosis
2014
Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients
1999
Quality Control for Spirometry in Preschool Children with and without Lung Disease
2004
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Cystic Fibrosis Since 1938
2005
Outcomes of Intensive Care Unit Care in Adults with Cystic Fibrosis
2001
Forced Expiratory Flows and Volumes in Infants
2000
Pulmonary Function Tests in Preschool Children with Cystic Fibrosis
2002
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Inflammation, Infection, and Pulmonary Function in Infants and Young Children with Cystic Fibrosis
2002
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Relative Ability of Full and Partial Forced Expiratory Maneuvers to Identify Diminished Airway Function in Infants with Cystic Fibrosis
2002
Inflammatory Response in Airway Epithelial Cells Isolated from Patients with Cystic Fibrosis
2002
The Richmond Agitation–Sedation Scale
2002 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis
1994
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Sleep Apnea and Heart Failure
2003
Effects of Viral Lower Respiratory Tract Infection on Lung Function in Infants With Cystic Fibrosis
1999
Implications of Rewiring Bacterial Quorum Sensing
2007 StandoutNobel
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease
1999
Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment.
1994
Caregiving for children and adults with chronic conditions: Introduction to the special issue.
1998
IL-17 and Th17 Cells
2009 Standout
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure
2003
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals
1996
Pathophysiology of Sleep Apnea
2010 Standout
Selective Activation of Inflammatory Pathways by Intermittent Hypoxia in Obstructive Sleep Apnea Syndrome
2005
Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
2002
Lung Infections Associated with Cystic Fibrosis
2002 Standout
A Mutation in the Surfactant Protein C Gene Associated with Familial Interstitial Lung Disease
2001
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Works of Howard Eigen being referenced
Longitudinal evaluation of pulmonary function in infants and very young children with cystic fibrosis
1993
Bronchodilator Responsiveness in Infants and Young Children with Cystic Fibrosis
1988
Bronchodilator responsiveness in infants with bronchiolitis
1994
Parental Response to Cystic Fibrosis: A Contextual Analysis of the Diagnosis Phase
1992
Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy
2004
Lower respiratory illness in infants and young children with cystic fibrosis
1997
A double-blind, randomized study of sodium cromoglycate versus placebo in patients with cystic fibrosis and bronchial hyperreactivity
1990
Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
1996
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis
1995
Infants with cystic fibrosis: Pulmonary function at diagnosis
1988
Airway Reactivity in Cystic Fibrosis
1990
Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: A prospective randomized study
1991
Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma
1992
Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis
1998
Use of maximal expiratory flows to evaluate central airways obstruction in infants
1989
Current concepts on interstitial lung disease in children
1999
Airway responsiveness in infants following bronchiolitis
1992
TNF-α, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients
1996
Assessment of Airway Responsiveness in Infants with Cystic Fibrosis
1991
Clinical-Behavioral Aspects of Cystic Fibrosis: Directions for Future Research
1987
Spirometry in 3- to 6-Year-Old Children with Cystic Fibrosis
2002
Spirometric Pulmonary Function in Healthy Preschool Children
2001
Risks of Alternate-Day Prednisone in Patients With Cystic Fibrosis
1991
Role strain in couples with and without a child with a chronic illness: Associations with marital satisfaction, intimacy, and daily mood.
1998
Predictability and consequences of spontaneous extubation in a pediatric ICU
1985
The impact of caregiving and role strain on family life: Comparisons between mothers of children with cystic fibrosis and matched controls.
1992
Bleomycin lung injury in children. Pathophysiology and guidelines for management.
1985
Airway reactivity in cystic fibrosis
1991
TNF‐α, IL‐8, soluble ICAM‐1, and neutrophils in sputum of cystic fibrosis patients
1996
Total respiratory system compliance in asymptomatic infants with cystic fibrosis.
1987